Method for extracting and separating ginkgolide B from ginkgo leaves
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 黑龙江天宏药业股份有限公司
- Publication Date
- 2013-01-23
Abstract
Description
technical field
[0001] The invention relates to a method for extracting ginkgolide B. Background technique
[0002] Ginkgolide is currently one of the most powerful and specific platelet activating factor (PAF) receptor blockers. Ginkgolide B has the strongest blocking effect on PAF receptor among ginkgolides, which can be eliminated in a dose-dependent manner. Platelet aggregation caused by PAF, thereby preventing the formation of thrombus. Pharmacological studies have shown that ginkgolide B has anti-allergic, anti-inflammatory, anti-shock effects, and also has protective effects on ischemic injury and organ transplant rejection. Ginkgolide B is relatively low in the commercially available Ginkgo biloba extract and has a specific structure. It is difficult to obtain high-purity and high-yield Ginkgolide B through extraction and separation.
[0003] The inventors have consulted domestic and foreign literature, and the authorized inventions or patents directly related to t...